[Dibekacin treatment of infectious complications of abdominal surgery].
Major abdominal surgery often involves severe postoperative infections with various pathogens: enterobacteriaceae, staphylococcus and anaerobic bacteria. For this reason a strong antibiotherapy can be necessary in the case of an infectious disease. Dibekacin was administered at a daily dose of 3 mg/kg to 22 patients suffering from very severe postoperative infection. In all the cases dibekacin was combined with a beta-lactamine and in some with nitro-imidazole derivative. The results were especially favourable in all of these cases and a good tolerance was observed.
D000005:Abdomen / Q000601:surgery*; D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy*; D003982:Dibekacin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy
D003982:Dibekacin; D007612:Kanamycin
Traitement par la dibékacine des complications infectieuses de la chirurgie abdominale.